Potential adverse events which may be associated with the use of a stent in the common and/or external iliac arteries include, but are not limited to: Abrupt closure, Allergic reactions to procedural medications, contrast dye or device materials, Amaurosis fugax, Aneurysm, Angina/coronary ischemia, Arrhythmia, Arterial occlusion or thrombosis at puncture site or remote site, Arteriovenous fistula, Bacteremia or septicemia, Bleeding from anticoagulant or antiplatelet medications, Bleeding, with or without transfusion, Cerebral edema, Cerebral hemorrhage, Cerebral ischemia or transient ischemic attack (TIA), Congestive heart failure (CHF), Death, Detachment of a component of the device system, Embolism (air, tissue, thrombus), Emergent or urgent endarterectomy surgery (CEA), Fever, Filter thrombosis or occlusion, Fluid overload, Groin hematoma, with or without surgical repair, Hemorrhage, with or without transfusion, Hyperperfusion syndrome, Hypotension or hypertension. Infection and/or pain at the puncture site, Ischemia or infarction of tissue/organ, Myocardial infarction (MI), Pain (head, neck), Pseudoaneurysm, femoral, Renal failure/insufficiency (new or worsening), Restenosis of stented segment, Seizure, Severe unilateral headache, Slow/no flow during procedure, Stent/filter collapse or fracture, Stent/filter entanglement or damage, Stent/filter failure to deploy, Stent embolization, migration or misplacement, Stent or vessel thrombosis/occlusion, Stroke/cerebrovascular accident (CVA), Total occlusion of carotid artery, Vessel dissection, flap, perforation, or rupture,Vessel spasm or recoil.